In addition, in the therapeutic mechanism, it provided a protective role in the stomach by gel microspheres, a targeted effect in IBS by IL-1β monoclonal antibodies, and controlled release of 5-ASA in IBS as well as gut microbiota remodeling by fermentation. The gene discussed is IL1B; the disease is irritable bowel syndrome.